Although progerin overexpression has not yet been utilized in an iPSC model of ALS, it has been applied to iPSC‐derived midbrain dopaminergic neurons in a Parkinson's disease (PD) model (Miller et al., 2013). This evidence concerns the gene LMNA and Parkinson disease.